Related Experiment Videos
Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity
Hayat Onyüksel1, Beena Ashok, Sumeet Dagar
1Department of Biopharmaceutical Sciences, University of Illinois at Chicago, IL 60612, Chicago, USA.
Peptides
|April 2, 2003
Summary
Vasoactive intestinal peptide (VIP) interaction with rigid liposomes showed minimal effects on its structure and short-term vasodilation. Overnight incubation, however, significantly enhanced VIP
Area of Science:
- Pharmacology
- Biophysics
- Cardiovascular Research
Background:
- Vasoactive intestinal peptide (VIP) is a crucial regulator of various physiological processes, including vasodilation.
- Liposomes, particularly those composed of gel phase phospholipids, are investigated for their potential in drug delivery and modulation of peptide activity.
- Understanding peptide-liposome interactions is key to developing targeted therapies.
Purpose of the Study:
- To investigate the interaction between vasoactive intestinal peptide (VIP) and rigid liposomes made of gel phase phospholipids.
- To assess the impact of these interactions on VIP's secondary structure and its vasodilatory function in vivo.
Main Methods:
- Incubation of VIP with small unilamellar gel phase liposomes (DPPC/ePG) under varying conditions (temperature, time).
- Analysis of VIP secondary structure using biophysical techniques.
- In vivo assessment of VIP-induced vasodilation in the hamster cheek pouch microcirculation.
Main Results:
- Short-term incubation (2h) of VIP with liposomes did not alter VIP's secondary structure or significantly affect its vasodilatory capacity.
- Overnight incubation of VIP with gel phase liposomes at 4°C significantly potentiated vasodilation compared to aqueous VIP.
- The observed vasodilation was independent of liposome size and the ratio of VIP to phospholipids.
Conclusions:
- Short-term interactions between VIP and rigid phospholipid bilayers have limited impact on VIP's vasoreactivity.
- Prolonged incubation allows for significant potentiation of VIP's vasodilatory effects, suggesting a time-dependent interaction mechanism.
- These findings have implications for the use of liposomes in modulating peptide-based therapeutics.